Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.

阅读量:

34

作者:

EM SagatysL Zhang

展开

摘要:

The clinical course of patients with chronic lymphocytic leukemia (CLL) is heterogeneous, with some patients experiencing rapid disease progression and others living for decades without requiring treatment. The Rai and Binet clinical staging systems are used to define disease extent and predict survival. The pathology laboratory also provides important prognostic information.A review of the literature was performed on the subject of staging in CLL from clinical and pathologic standpoints. This article also reviews currently available diagnostic approaches related to disease prognosis and to timing of treatment and follow-up in patients with CLL.Novel biological and cytogenetic features such as immunoglobulin heavy-chain variable gene segment [IgVH], genomic aberrations including del(17p13), del(11q23), del(13q14), and trisomy 12, serum markers (thymidine kinase and beta-2 microglobulin), and cellular markers (CD38 and ZAP70) have become increasingly important in predicting prognosis at the time of diagnosis.Current prognostic factors directly or indirectly influence the management of patients with CLL and help to predict treatment-free and overall survival.

展开

DOI:

doi:http://dx.doi.org/

被引量:

81

年份:

2012

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

引用走势

2014
被引量:20

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用